Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 2,179 shares at $92.95 ($203K) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($203k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.95 | 1,653 | $154K | 75.7% |
| 2 | $93.78 | 526 | $49K | 24.3% |
| Total | $93.15 avg | 2,179 | $203K | 100% |
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |